BioLargo (BLGO) Competitors $0.20 0.00 (-0.10%) As of 07/15/2025 03:59 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock BLGO vs. AMTX, VGAS, LODE, ZTEK, TSE, ALTO, ORGN, LNZA, FSI, and LOOPShould you be buying BioLargo stock or one of its competitors? The main competitors of BioLargo include Aemetis (AMTX), Verde Clean Fuels (VGAS), Comstock (LODE), Zentek (ZTEK), Trinseo (TSE), Alto Ingredients (ALTO), Origin Materials (ORGN), LanzaTech Global (LNZA), Flexible Solutions International (FSI), and Loop Industries (LOOP). These companies are all part of the "chemicals" industry. BioLargo vs. Its Competitors Aemetis Verde Clean Fuels Comstock Zentek Trinseo Alto Ingredients Origin Materials LanzaTech Global Flexible Solutions International Loop Industries BioLargo (NASDAQ:BLGO) and Aemetis (NASDAQ:AMTX) are both small-cap chemicals companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, analyst recommendations, institutional ownership, profitability, valuation, media sentiment, dividends and risk. Do insiders & institutionals have more ownership in BLGO or AMTX? 0.0% of BioLargo shares are owned by institutional investors. Comparatively, 27.0% of Aemetis shares are owned by institutional investors. 20.3% of BioLargo shares are owned by insiders. Comparatively, 15.9% of Aemetis shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Which has preferable earnings & valuation, BLGO or AMTX? BioLargo has higher earnings, but lower revenue than Aemetis. BioLargo is trading at a lower price-to-earnings ratio than Aemetis, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBioLargo$12.23M4.99-$3.50M-$0.01-19.95Aemetis$267.64M0.62-$87.54M-$1.87-1.60 Does the media favor BLGO or AMTX? In the previous week, BioLargo and BioLargo both had 1 articles in the media. Aemetis' average media sentiment score of 1.87 beat BioLargo's score of 1.16 indicating that Aemetis is being referred to more favorably in the news media. Company Overall Sentiment BioLargo Positive Aemetis Very Positive Which has more volatility & risk, BLGO or AMTX? BioLargo has a beta of 0.11, meaning that its share price is 89% less volatile than the S&P 500. Comparatively, Aemetis has a beta of 1.57, meaning that its share price is 57% more volatile than the S&P 500. Do analysts rate BLGO or AMTX? Aemetis has a consensus price target of $13.63, suggesting a potential upside of 355.69%. Given Aemetis' stronger consensus rating and higher probable upside, analysts plainly believe Aemetis is more favorable than BioLargo.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BioLargo 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Aemetis 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.75 Is BLGO or AMTX more profitable? BioLargo has a net margin of -11.45% compared to Aemetis' net margin of -36.92%. Aemetis' return on equity of 0.00% beat BioLargo's return on equity.Company Net Margins Return on Equity Return on Assets BioLargo-11.45% -39.90% -22.06% Aemetis -36.92%N/A -35.80% SummaryAemetis beats BioLargo on 9 of the 15 factors compared between the two stocks. Get BioLargo News Delivered to You Automatically Sign up to receive the latest news and ratings for BLGO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BLGO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BLGO vs. The Competition Export to ExcelMetricBioLargoChemicals & allied products IndustryConstruction SectorNASDAQ ExchangeMarket Cap$61.13M$11.86B$9.43B$9.30BDividend YieldN/A1.09%2.02%4.03%P/E Ratio-19.95N/A15.9119.58Price / Sales4.993.58115.2893.84Price / CashN/A14.8014.8657.93Price / Book19.9511.414.445.54Net Income-$3.50M$989.69M$622.34M$257.73M7 Day Performance-0.25%-0.13%-2.74%-0.08%1 Month Performance-0.10%-0.05%2.77%8.09%1 Year Performance-24.83%-12.42%92.35%13.02% BioLargo Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BLGOBioLargo0.7493 of 5 stars$0.20-0.1%N/A-21.7%$61.13M$12.23M-19.9530Positive NewsAMTXAemetis2.7305 of 5 stars$3.49+5.4%$13.63+290.4%-17.3%$193.24M$267.64M-1.87160Positive NewsVGASVerde Clean Fuels0.25 of 5 stars$3.43+0.3%N/A-21.2%$152.81MN/A-7.152LODEComstock0.796 of 5 stars$3.70-1.9%$26.00+602.7%+124.4%$119.94M$3.38M-30.8330ZTEKZentek0.5084 of 5 stars$1.11flatN/A-12.0%$116.23M$1.22M-18.5024Gap DownTSETrinseo1.0203 of 5 stars$2.96+2.1%N/A+2.7%$105.52M$3.51B-0.302,950ALTOAlto Ingredients3.2377 of 5 stars$1.24+0.8%$5.50+343.5%-25.6%$95.00M$965.26M-1.51420ORGNOrigin Materials1.9224 of 5 stars$0.61+7.6%$1.50+147.8%-41.7%$90.77M$31.28M-0.90160Positive NewsLNZALanzaTech Global2.5713 of 5 stars$0.31+12.6%$2.00+548.5%-85.8%$71.54M$49.59M-0.463FSIFlexible Solutions International2.6475 of 5 stars$5.62-6.3%N/A+200.3%$71.08M$36.48M17.0340LOOPLoop Industries1.5908 of 5 stars$1.23+2.5%N/A-39.7%$58.69M$10.89M-3.8490News CoveragePositive NewsEarnings ReportUpcoming Earnings Related Companies and Tools Related Companies AMTX Competitors VGAS Competitors LODE Competitors ZTEK Competitors TSE Competitors ALTO Competitors ORGN Competitors LNZA Competitors FSI Competitors LOOP Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BLGO) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhy Elon is funding the “Quantum Power Grid”Elon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioLargo, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioLargo With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.